DXNLX | UOPIX | DXNLX / UOPIX | |
Total Expense Ratio | 1.26 | 1.53 | 82% |
Annual Report Gross Expense Ratio | 1.98 | 1.53 | 129% |
Fund Existence | 9 years | 27 years | - |
Gain YTD | -7.873 | -15.741 | 50% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 25000 | 15000 | 167% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4M | 901M | 0% |
Annual Yield % from dividends | 3.12 | 0.50 | 620% |
Returns for 1 year | 9.30 | 6.87 | 135% |
Returns for 3 years | 70.21 | 80.58 | 87% |
Returns for 5 years | 99.29 | 114.46 | 87% |
Returns for 10 years | N/A | 511.58 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DSTL | 53.05 | 0.38 | +0.72% |
Distillate US Fdmtl Stblty & Val ETF | |||
FMED | 23.41 | 0.12 | +0.52% |
Fidelity Disruptive Medicine ETF | |||
HPS | 14.45 | 0.06 | +0.42% |
John Hancock Preferred Income Fund III | |||
PZC | 6.39 | -0.06 | -0.93% |
PIMCO California Municipal Income Fund III | |||
IPOS | 13.53 | -0.20 | -1.49% |
Renaissance International IPO ETF |